Nortrel 7/7/7 Kit
Product Images NDC 0555-9012

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nortrel 7/7/7 (NDC 0555-9012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of the active ingredient in Nortrel 7/7/7, showing a steroid backbone with hydroxyl, methyl, and aldehyde functional groups. This represents the chemical structure of Norethindrone.*

FDA Label Image

Image 2

Chemical structure diagram of the active ingredient in Nortrel 7/7/7, depicting the molecular structure of Norethindrone, a synthetic progestin used in combination oral contraceptives.*

FDA Label Image

Image 3

A bar graph showing mortality rates (number of deaths per 100,000 women per year) categorized by age groups (15-24, 25-34, 35-44, 45+) and smoking status (ever users and controls, both smokers and non-smokers). The graph compares these groups across different age ranges, illustrating trends in mortality rates with age and smoking history.*

FDA Label Image

Image 4

A forest plot chart showing effect estimates (odds ratios and risk ratios) with confidence intervals from various cohort studies on contraceptive use. The horizontal axis ranges from -1.5 to 2, displaying study names on the left and corresponding estimates with confidence intervals on the right.*

FDA Label Image

Image 5

An instructional illustration showing a hand holding and pointing to a Nortrel 7/7/7 oral contraceptive pill kit. The kit features a 28-day regimen with circular pill compartments arranged by day of the week to aid daily dosing.*

FDA Label Image

Image 6

Packaging label for Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP, triphasic regimen) kit by Teva Pharmaceuticals USA, Inc. The box indicates 6 blister cards with 28 tablets each, for a 28-day regimen. Storage instructions and usual dosage guidance are included, along with the Teva logo and a QR code for more information.*

FDA Label Image

Image 7

Packaging label for Nortrel 7/7/7 (28 Day Regimen) kit containing norethindrone and ethinyl estradiol tablets USP in a triphasic regimen. The label shows the NDC 0555-9012-58 and indicates six blister cards with 28 tablets each. The labeler is Teva Pharmaceuticals USA, Inc., and the packaging includes warnings and instructions typical for an oral contraceptive kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.